European Archives - Page 512 of 1424 - European Medical Journal

Antifibrotic Treatment Efficacy in Progressive Pulmonary Fibrosis

In cases of pulmonary fibrosis attributable to interstitial lung disease, whether the aetiology is known or unknown, the presence…

Transforming Management of SEA

Asthma affects approximately 262 million people globally,1 with the number of asthma incidents having increased by around 15% over the…

Understanding COPD: Current Treatments and Emerging Breakthroughs

Exploring Chronic obstructive pulmonary disease (COPD), this infographic highlights the global incidence, current management strategies…

Overcoming the Challenges of Increasing Urbanisation in Respiratory Health

IN THIS year’s European Respiratory Society (ERS) Congress, a session focused on the current challenges related to the impact of…

Phase IIb Study Design of Inhaled Pirfenidone for Progressive Pulmonary Fibrosis Treatment

Progressive pulmonary fibrosis (PPF) is an increasingly recognised condition, defined in 2022 to address the progression of pulmonary…

The Future of Lung Transplantation in Cystic Fibrosis

AN INSIGHTFUL session on the future of lung transplantation presented at this year’s European Respiratory Society (ERS) Congress explored…

ERS 2024 Abstract Highlights

The following abstract highlights spotlight selected abstracts presented at the European Respiratory Society (ERS) Congress 2024. They…

Patient–Planet Priority in Respiratory Care

Healthcare decision-makers are facing significant challenges that will intensify in the coming years as they work to address health…

Inflammatory Processes in COPD

A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes resulting in airway…

Understanding Bronchiectasis Pathogenesis and Exacerbation

The chronic and progressive inflammatory disease bronchiectasis is characterised by permanent bronchi dilation and by symptoms such as…